Latest filing published 02 Jun 2026 for Medicenna Therapeutics Corp., €22k. Read the official filing
Fahar Merchant discloses dealings in Medicenna Therapeutics Corp. to SEDI. Over a trading history stretching from 1 March 2017 to 28 May 2026, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 2 June 2026, the filings show a transaction worth €22k in Medicenna Therapeutics Corp. Between a trade and the moment it shows up on SEDI, the median delay is 5 days. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations